Jun 21 |
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation
|
Jun 4 |
Wall Street Analysts Believe Terns Pharmaceuticals (TERN) Could Rally 136.44%: Here's is How to Trade
|
Jun 3 |
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
|
May 30 |
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
|
May 17 |
Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
|
May 13 |
Terns Pharmaceuticals Inc (TERN) Q1 2024 Earnings: Misses Analyst Net Loss Projections
|
May 13 |
Terns Pharmaceuticals GAAP EPS of -$0.30
|
May 13 |
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
|
May 8 |
Terns Pharmaceuticals Announces Leadership Changes
|
May 7 |
Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
|